Nutrien (NTR) Stock Forecast & Price Target

$51.59 +0.09 (+0.17%)

As of 01/17/2025 03:59 PM Eastern

Nutrien - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 17 Analyst Ratings

Sell
1

Hold
5

Buy
11

Based on 17 Wall Street analysts who have issued ratings for Nutrien in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 17 analysts, 1 has given a sell rating, 5 have given a hold rating, and 11 have given a buy rating for NTR.

Consensus Price Target

$58.33
13.08% Upside

According to the 17 analysts' twelve-month price targets for Nutrien, the average price target is $58.33. The highest price target for NTR is $75.00, while the lowest price target for NTR is $50.00. The average price target represents a forecasted upside of 13.08% from the current price of $51.59.

Get the Latest News and Ratings for NTR and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Nutrien and its competitors.

NTR Analyst Ratings Over Time

Type	Current Forecast 1/21/24 to 1/20/25	1 Month Ago 12/22/23 to 12/21/24	3 Months Ago 10/23/23 to 10/22/24	1 Year Ago 1/21/23 to 1/21/24
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	11 Buy rating(s)	11 Buy rating(s)	10 Buy rating(s)	9 Buy rating(s)
Hold	5 Hold rating(s)	4 Hold rating(s)	6 Hold rating(s)	9 Hold rating(s)
Sell	1 Sell rating(s)	3 Sell rating(s)	3 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$58.33	$58.95	$60.67	$76.00
Forecasted Upside	13.08% Upside	32.23% Upside	26.06% Upside	47.72% Upside
Consensus Rating	Moderate Buy	Hold	Hold	Hold

NTR Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

NTR Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Nutrien Stock vs. The Competition

Type	Nutrien	Basic Materials Companies	S&P 500
Consensus Rating Score	2.59	2.76	2.52
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	13.08% Upside	130.71% Upside	12.44% Upside
News Sentiment Rating	Positive News See Recent NTR News	Neutral News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
1/13/2025	Piper Sandler 2 of 5 stars	C. Neivert Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Underweight ➝ Overweight	$50.00 ➝ $58.00	+19.69%
1/13/2025	JPMorgan Chase & Co. 3 of 5 stars	Jeffrey Zekauskas Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Underweight ➝ Neutral	$40.00 ➝ $50.00	+3.18%
12/12/2024	Oppenheimer 3 of 5 stars		Initiated Coverage	Outperform	$60.00	+25.31%
12/10/2024	CIBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperformer	$60.00 ➝ $55.00	+12.45%
12/3/2024	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Hansen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Market Perform ➝ Outperform	$58.00 ➝ $60.00	+25.63%
11/12/2024	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy	$63.00 ➝ $61.00	+29.32%
10/10/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Spector Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Neutral	$66.00 ➝ $51.00	+4.04%
9/24/2024	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Garchitorena Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Overweight ➝ Equal Weight	$62.00 ➝ $50.00	+5.31%
9/20/2024	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Outperform	$60.00 ➝ $60.00	+25.26%
9/10/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Samuelson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Neutral	$69.00 ➝ $53.00	+14.99%
Get the Latest News and Ratings for NTR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Nutrien and its competitors with MarketBeat's FREE daily newsletter.
8/16/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Overweight ➝ Overweight	$68.00 ➝ $55.00	+18.69%
8/12/2024	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Sector Outperform ➝ Sector Outperform	$66.00 ➝ $59.00	+26.96%
8/9/2024	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform ➝ Outperform	$80.00 ➝ $75.00	+63.58%
8/8/2024	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	E. Rodriguez Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Neutral ➝ Neutral	$55.00 ➝ $52.00	+14.66%
8/2/2024	Hsbc Global Res Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Seshadri Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Hold ➝ Moderate Sell
8/2/2024	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Hold ➝ Reduce
4/29/2024	Berenberg Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy	$60.00 ➝ $66.00	+25.59%
3/26/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$62.00	+17.92%
3/1/2024	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform	$66.00	+26.36%
1/19/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$72.00 ➝ $75.00	+49.31%
11/30/2023	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Outperform ➝ Neutral
7/25/2023	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Equal Weight ➝ Equal Weight	$70.00	+5.69%
6/8/2023	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$94.00 ➝ $85.00	+44.73%
5/11/2023	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$70.00 ➝ $60.00	-5.30%
3/28/2023	Erste Group Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Hold
1/20/2023	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy	$87.00 ➝ $86.00	+12.82%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 12:48 PM ET.

Should I Buy Nutrien Stock? NTR Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, January 10, 2025. Please send any questions or comments about these Nutrien pros and cons to contact@marketbeat.com.

Nutrien
Bull Case

Here are some ways that investors could benefit from investing in Nutrien Ltd.:

Nutrien Ltd. recently increased its quarterly dividend to $0.939, representing an annualized dividend of $3.76 and a yield of 8.30%. This increase indicates a commitment to returning value to shareholders, which can be attractive for income-focused investors.
The stock is currently trading at $45.28, which is below the consensus price target of $58.95. This suggests potential upside for investors if the stock price aligns with analyst expectations.
Despite a recent earnings miss, Nutrien Ltd. reported revenue of $5.35 billion, exceeding analyst estimates. This indicates strong operational performance and resilience in generating sales, which can be a positive sign for future growth.
Analysts have a consensus rating of "Hold" with a significant number of buy ratings (11 out of 18). This suggests that many analysts believe the stock has potential for appreciation, which can instill confidence in investors.
The company operates in the agricultural sector, providing essential crop inputs and services, which are critical for food production. This positions Nutrien Ltd. favorably in a sector that is likely to see continued demand growth.

Nutrien
Bear Case

Investors should be bearish about investing in Nutrien Ltd. for these reasons:

The company has a high payout ratio of 144.97%, which indicates that it is paying out more in dividends than it is earning. This could raise concerns about the sustainability of future dividend payments.
Recent analyst downgrades, including cuts from Goldman Sachs and UBS, suggest a cautious outlook on the stock, which may indicate potential challenges ahead for the company.
Nutrien Ltd. experienced a year-over-year revenue decline of 5.0%, which could signal underlying issues in its business model or market conditions that may affect future profitability.
The stock has a relatively high P/E ratio of 30.39, which may indicate that it is overvalued compared to its earnings. This could deter value-focused investors looking for more attractive entry points.
With a beta of 0.80, the stock is less volatile than the market, which may not appeal to investors seeking high-risk, high-reward opportunities. This could limit its attractiveness for those looking for aggressive growth investments.

NTR Forecast - Frequently Asked Questions

: According to the research reports of 17 Wall Street equities research analysts, the average twelve-month stock price forecast for Nutrien is $58.33, with a high forecast of $75.00 and a low forecast of $50.00.
: 17 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Nutrien in the last twelve months. There is currently 1 sell rating, 5 hold ratings and 11 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" NTR shares.
: According to analysts, Nutrien's stock has a predicted upside of 13.08% based on their 12-month stock forecasts.
: Over the previous 90 days, Nutrien's stock had 3 upgrades by analysts.
: Nutrien has been rated by research analysts at CIBC, JPMorgan Chase & Co., Oppenheimer, Piper Sandler, Raymond James, and TD Securities in the past 90 days.
: Analysts like Nutrien less than other "basic materials" companies. The consensus rating score for Nutrien is 2.59 while the average consensus rating score for "basic materials" companies is 2.76. Learn more on how NTR compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

This page (NYSE:NTR) was last updated on 1/20/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Nutrien (NTR) Stock Forecast & Price Target